Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Annual global sales of Brensocatib two years after market launch  | Categorical | 5 | 7 months ago | ||
Will Brensocatib receive FDA approval for bronchiectasis by end of 2024? | Binary | 5 | 7 months ago | ||
Will Brensocatib be licensed for marketing outside the US by end of 2024? | Binary | 4 | 7 months ago | ||
Insmed's share price range on the first trading day after FDA approval of Brensocatib | Categorical | 4 | 7 months ago | ||
Number of new approved indications for Brensocatib within five years | Categorical | 4 | 7 months ago | ||
Will Insmed's market cap reach $10 billion due to Brensocatib by mid-2025? | Binary | 3 | 7 months ago |